Main Logo

Society for Pediatric Radiology – Poster Archive


Final ID: Poster #: SCI-048

Performance of whole-body MRI in evaluation of pediatric oncology patients: a single center experience.

Purpose or Case Report: Whole-body magnetic resonance imaging (WB-MRI) is an increasingly important tool in pediatric oncology. Optimized WB-MRI protocols allow for abbreviated imaging of young patients with excellent tissue contrast/resolution and without ionizing radiation exposure. Recent data suggest a role for WB-MRI in pediatric cancer staging, cancer predisposition syndrome (CPS) surveillance and evaluation for chemotherapy-related osteonecrosis. The purpose of this study is to evaluate the performance of WB-MRI in these populations.
Methods & Materials: A single institution IRB-approved retrospective review of radiology reports identified pediatric patients who underwent WB-MRI in the years 2002-2016. Electronic records were queried to identify patients undergoing WB-MRI for cancer staging, CPS surveillance or evaluation for osteonecrosis. A single pediatric radiologist reviewed all studies to confirm findings in the report. Electronic medical records of imaging and notes within one year of WB-MRI were reviewed to assess impact on clinical management.
Results: A total of 24 patients were included: 12 undergoing cancer staging (5 neuroblastoma, 2 Ewing sarcoma, 5 lymphoma), 5 undergoing CPS surveillance (4 hereditary paraganglioma-pheochromocytoma syndrome (HPPS), 1 Li-Fraumeni syndrome) and 7 undergoing evaluation for osteonecrosis. In the staging group, WB-MRI demonstrated known disease in 12 of 12 (100%) patients when compared to concurrent scintigraphy, PET, SPECT or CT/MR imaging (fig 1). In the CPS group, no new lesions were seen on follow-up imaging in 5 of 5 patients (fig 2). WB-MRI identified known lesions in 1 of 2 (50%) HPPS patients, failing to detect a vertebral lesion seen on PET imaging. In the osteonecrosis group, WB-MRI confirmed osteonecrosis in 6 of 7 patients (86%) and ruled it out in 1 of 7 (14%). Imaging affected the decision to continue, hold or restart steroids in all 6 patients with steroid-based treatment plans (fig 3). In one patient, WB-MRI identified an area of sub-clinical osteonecrosis in the femoral head.
Conclusions: This preliminary single-institution study demonstrates the value of WB-MRI in pediatric cancer staging, surveillance and chemotherapy-related osteonecrosis. Study limitations included population size and retrospective nature of the analysis. We note that WB-MRI was used as an adjunct to other imaging modalities in our population, and further studies will be needed to assess WB-MRI performance in the pediatric oncology population as the sole surveillance imaging modality.
  • Hampilos, Perry  ( Harvard Medical School , Boston , Massachusetts , United States )
  • Friedmann, Alison  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Gee, Michael  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
Session Info:

Posters - Scientific

Nuclear Imaging/Oncology

SPR Posters - Scientific

More abstracts on this topic:
More abstracts from these authors:
Fetal MRI Troubleshooting: Strategies to Improve Image Quality and Reduce Artifacts

Machado-rivas Fedel, Jaimes Camilo, Kirsch John E, Gee Michael

Current and Emerging Applications of Pediatric Gastrointestinal Tract Sonography

Gale Heather, Gee Michael, Westra Sjirk, Lee Edward, Nimkin Katherine

You have to be authorized to contact abstract author. Please, Login or Signup.

Please note that this is a separate login, not connected with your credentials used for the SPR main website.

Not Available